Concomitant Boost Fractionation

Concomitant Boost Fractionation is a radiation therapy scheduling strategy (genus) that distinguishes itself by delivering a lower-dose, continuous primary treatment field concurrently with a higher-dose, localized boost field to accelerate tumor cell kill while moderating normal tissue toxicity (differentia).

66

Publications

3.3K

Citations

460

Authors

132

Institutions

Publications per year

2017–2026

6

Variants

Concomitant Boost

Publications

66

1–5 of 66

Authors

460

  1. RS
    Rupert Schmidt‐Ullrich

    Virginia Commonwealth University Medical Center, United States

    5 publications · 235 citations

    5

    h-index

  2. LB
    Louis B. Harrison

    Memorial Sloan Kettering Cancer Center, United States

    4 publications · 219 citations

    4

    h-index

  3. CR
    Christopher R. Johnson

    University of Utah, United States

    4 publications · 207 citations

    4

    h-index

  4. VV
    Vincenzo Valentini

    Università Cattolica del Sacro Cuore, Italy

    4 publications · 149 citations

    4

    h-index

  5. DG
    David G. Pfister

    Memorial Sloan Kettering Cancer Center, United States

    3 publications · 142 citations

    3

    h-index

1–5 of 460

Venues

  1. 15

    h-index

  2. Journal of Clinical Oncology

    8 publications · 771 citations

    8

    h-index

  3. Head & Neck

    5 publications · 362 citations

    5

    h-index

  4. Radiotherapy and Oncology

    3 publications · 150 citations

    3

    h-index

  5. PubMed

    Repository · 3 publications · 45 citations

    3

    h-index

1–5